1. Home
  2. EVG vs STXS Comparison

EVG vs STXS Comparison

Compare EVG & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVG
  • STXS
  • Stock Information
  • Founded
  • EVG 2005
  • STXS 1990
  • Country
  • EVG United States
  • STXS United States
  • Employees
  • EVG N/A
  • STXS N/A
  • Industry
  • EVG Investment Managers
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • EVG Finance
  • STXS Health Care
  • Exchange
  • EVG Nasdaq
  • STXS Nasdaq
  • Market Cap
  • EVG 146.4M
  • STXS 151.3M
  • IPO Year
  • EVG N/A
  • STXS 2004
  • Fundamental
  • Price
  • EVG $10.80
  • STXS $2.13
  • Analyst Decision
  • EVG
  • STXS
  • Analyst Count
  • EVG 0
  • STXS 0
  • Target Price
  • EVG N/A
  • STXS N/A
  • AVG Volume (30 Days)
  • EVG 49.4K
  • STXS 207.9K
  • Earning Date
  • EVG 01-01-0001
  • STXS 08-11-2025
  • Dividend Yield
  • EVG 8.68%
  • STXS N/A
  • EPS Growth
  • EVG N/A
  • STXS N/A
  • EPS
  • EVG N/A
  • STXS N/A
  • Revenue
  • EVG N/A
  • STXS $27,510,000.00
  • Revenue This Year
  • EVG N/A
  • STXS $25.90
  • Revenue Next Year
  • EVG N/A
  • STXS $60.57
  • P/E Ratio
  • EVG N/A
  • STXS N/A
  • Revenue Growth
  • EVG N/A
  • STXS 1.50
  • 52 Week Low
  • EVG $9.13
  • STXS $1.54
  • 52 Week High
  • EVG $10.86
  • STXS $2.72
  • Technical
  • Relative Strength Index (RSI)
  • EVG 47.01
  • STXS 47.58
  • Support Level
  • EVG $10.80
  • STXS $2.06
  • Resistance Level
  • EVG $11.11
  • STXS $2.36
  • Average True Range (ATR)
  • EVG 0.10
  • STXS 0.11
  • MACD
  • EVG -0.00
  • STXS -0.01
  • Stochastic Oscillator
  • EVG 22.50
  • STXS 19.70

About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: